Cargando…
Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine: two cases
We present two cases of nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine. We discuss the initial presentation, investigation and management of these patients along with a discussion around the current evidence base for vaccine-induced nephrotic syndrome.
Autores principales: | Hartley, James Leon, Bailey, Neil, Sharma, Asheesh, Shawki, Howida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900021/ https://www.ncbi.nlm.nih.gov/pubmed/35246429 http://dx.doi.org/10.1136/bcr-2021-244638 |
Ejemplares similares
-
Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine
por: Lebedev, Larissa, et al.
Publicado: (2021) -
Minimal Change Nephrotic Syndrome with Acute Kidney Injury after the Administration of Pfizer-BioNTech COVID-19 Vaccine
por: Gulumsek, Erdinc, et al.
Publicado: (2023) -
Minimal change disease soon after Pfizer-BioNTech COVID-19 vaccination
por: Kobayashi, Seiji, et al.
Publicado: (2021) -
Relapse of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine
por: Komaba, Hirotaka, et al.
Publicado: (2021) -
Minimal risk of GBS relapse after Pfizer-BioNTech COVID-19 vaccination
Publicado: (2021)